278 related articles for article (PubMed ID: 16531819)
1. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
Bontkes HJ; Ruizendaal JJ; Kramer D; Santegoets SJ; Scheper RJ; de Gruijl TD; Meijer CJ; Hooijberg E
J Immunother; 2006; 29(2):188-200. PubMed ID: 16531819
[TBL] [Abstract][Full Text] [Related]
2. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
3. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).
Hu ZB; Quentmeier H; Meyer C; Kaufmann M; MacLeod RA; Drexler HG
Leuk Res; 2004 May; 28(5):509-15. PubMed ID: 15068904
[TBL] [Abstract][Full Text] [Related]
4. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model.
St Louis DC; Woodcock JB; Franzoso G; Blair PJ; Carlson LM; Murillo M; Wells MR; Williams AJ; Smoot DS; Kaushal S; Grimes JL; Harlan DM; Chute JP; June CH; Siebenlist U; Lee KP
J Immunol; 1999 Mar; 162(6):3237-48. PubMed ID: 10092775
[TBL] [Abstract][Full Text] [Related]
5. MUTZ-3-derived dendritic cells as an in vitro alternative model to CD34+ progenitor-derived dendritic cells for testing of chemical sensitizers.
Nelissen I; Selderslaghs I; Heuvel RV; Witters H; Verheyen GR; Schoeters G
Toxicol In Vitro; 2009 Dec; 23(8):1477-81. PubMed ID: 19732821
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
Chen LL; Ye F; Yu Y; Chen HZ; Zhang WW; Lü WG; Xie X
Gynecol Oncol; 2009 Jan; 112(1):199-204. PubMed ID: 19022493
[TBL] [Abstract][Full Text] [Related]
8. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
9. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
10. Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-beta.
Zhang LF; Okuma K; Tanaka R; Kodama A; Kondo K; Ansari AA; Tanaka Y
Exp Biol Med (Maywood); 2008 Jun; 233(6):721-31. PubMed ID: 18408138
[TBL] [Abstract][Full Text] [Related]
11. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
Ramadan G; Konings S; Kurup VP; Keever-Taylor CA
Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979
[TBL] [Abstract][Full Text] [Related]
12. [Dendritic cells (DC) induced from acute myeloid leukemia (AML) cells with cytokine cocktails].
Yan KH; You SG; Bian SG; Ma GJ; Ge W; Ma S; Liu SH; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):365-8. PubMed ID: 12941192
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.
Moldenhauer A; Nociari M; Lam G; Salama A; Rafii S; Moore MA
Stem Cells; 2004; 22(2):144-57. PubMed ID: 14990854
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
[TBL] [Abstract][Full Text] [Related]
15. IL-4 is more effective than IL-13 for in vitro differentiation of dendritic cells from peripheral blood mononuclear cells.
Ahn JS; Agrawal B
Int Immunol; 2005 Oct; 17(10):1337-46. PubMed ID: 16141241
[TBL] [Abstract][Full Text] [Related]
16. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
Pietra G; Mortarini R; Parmiani G; Anichini A
Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Moldenhauer A; Frank RC; Pinilla-Ibarz J; Holland G; Boccuni P; Scheinberg DA; Salama A; Seeger K; Moore MA; Nimer SD
J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
[TBL] [Abstract][Full Text] [Related]
18. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
[TBL] [Abstract][Full Text] [Related]
19. A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.
Santegoets SJ; Masterson AJ; van der Sluis PC; Lougheed SM; Fluitsma DM; van den Eertwegh AJ; Pinedo HM; Scheper RJ; de Gruijl TD
J Leukoc Biol; 2006 Dec; 80(6):1337-44. PubMed ID: 16959899
[TBL] [Abstract][Full Text] [Related]
20. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
